Abstract
In Madrid Region 6652 AIDS cases were diagnosed between 1982 and 1993. Visceral leishmaniasis (VL) was present in 166 (2.49%). VL frequency among injecting drug users proved higher than that for the other transmission categories (relative risk 2.57; 95% confidence interval 1.64–4.01). This could point to an alternative Leishmania transmission route via needle sharing.
References
Dereure J, Reynes F, Pratlong F, et al. Visceral leishmaniasis in HIV-infected patients in the south of France. Bull WHO 1995; 73: 245–246.
Altes J, Salas A, Riera M, et al. Visceral leishmaniasis: Another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 1991; 5: 201–207.
Alvar J. Leishmaniasis and AIDS co-infection: The Spanish example. Parasitol Today 1994; 10: 160–163.
Consejería de Salud de la Comunidad de Madrid. Vigilancia epidemiológica del AIDS/VIH. Informe no. 14, October 1994.
Alvar J, Jiménez M. Could infected drug-users be potential Leishmania infantum reservoirs? [Letter]. AIDS 1994; 8: 854.
Molina R, Cañavate C, Cercenado E, et al. Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patient using colonized Phebotomus perniciosus. AIDS 1994; 10: 160–163.
Alvar J, Gutiérrez-Solar B, Molina R, et al. Prevalence of Leishmania infection among AIDS patients [Letter]. Lancet 1992; 339: 1427.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amela, C., López-Gay, D., Alberdig, J.C. et al. Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients. Eur J Epidemiol 12, 91–92 (1996). https://doi.org/10.1007/BF00144435
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00144435